Leukocare

Leukocare AG is a biotechnology company specializing in the field of biopharmaceutical formulation development. Leukocare operates at the interface of active pharmaceutical ingredient and drug product development, combining extensive knowledge in formulation development with bioinformatics and artificial intelligence.The formulation development approach consists of two elements: a library containing up to 100 different regulatory-compliant excipients, and a rational development method matrix employing statistical software, self-learning algorithms, and state-of-the-art Design of Experiments (DoE). By leveraging AI components, Leukocare is able to specifically combine excipients, customizing stable formulations according to drug product requirements.